Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Heart (British Cardiac Society)|May 11, 2021
Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseasesGaurav S Gulsin, Matthew P M Graham-Brown, Iain B Squire, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
Overstimulation of the ergoreflex-A possible mechanism to explain symptoms in long COVIDShirley Sze, Daniel Pan, Alastair J Moss, et al.
Journal of the American College of Cardiology|December 6, 2005
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patientsThor Ueland, John Kjekshus, Stig S Frøland, et al.
Heart (British Cardiac Society)|July 10, 2017
Sacubitril/valsartan: beyond natriuretic peptidesJagdeep S S Singh, Louise M Burrell, Myriam Cherif, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 22, 2014
PKC-mediated toxicity of elevated glucose concentration on cardiomyocyte functionMark W Sims, James Winter, Sean Brennan, et al.
European Heart Journal|January 27, 2009
Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarctionSohail Q Khan, Kelvin Ng, Onkar Dhillon, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 11, 2010
Procalcitonin as a prognostic marker in patients with acute myocardial infarctionDominic Kelly, Sohail Q Khan, Onkar Dhillon, et al.
Pageof 12